CONMED Corporation (CNMD)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	197,705	188,177	152,770	142,976	95,454	51,388	27,709	24,749	35,597	73,908	93,998	95,247	109,716	97,201	99,872	52,919	46,009	49,187	40,744	80,648
Revenue (ttm)	US$ in thousands	1,305,025	1,286,126	1,274,003	1,260,907	1,244,743	1,168,565	1,139,075	1,098,613	1,045,472	1,068,576	1,042,315	1,020,286	1,010,636	989,493	978,501	881,125	862,458	874,495	870,250	950,728
Operating profit margin		15.15%	14.63%	11.99%	11.34%	7.67%	4.40%	2.43%	2.25%	3.40%	6.92%	9.02%	9.34%	10.86%	9.82%	10.21%	6.01%	5.33%	5.62%	4.68%	8.48%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $197,705K ÷ $1,305,025K
= 15.15%

CONMED Corporation's operating profit margin has shown fluctuations over the reported periods, ranging from as low as 2.25% in March 31, 2023, to as high as 15.15% in December 31, 2024. The trend indicates a general upward trajectory from the latter part of 2023 to the end of 2024, suggesting improving operational efficiency and profitability during this period. It is worth noting the significant increase in the operating profit margin from 9.02% in June 30, 2022, to 15.15% in December 31, 2024, indicating a notable enhancement in the company's ability to generate profits from its core operations. However, the gradual decline observed from September 30, 2022, to March 31, 2023, followed by a subsequent recovery, may require further investigation to understand the underlying factors driving these fluctuations. Overall, CONMED's operating profit margin performance demonstrates varying levels of profitability and efficiency over the reported periods.